Virtual Reality-Enhanced Parent Education in Neonatal Intensive Care
Virtual Reality-Enhanced Parent Education and Its Effect on Neonatal Intensive Care Practices: A Randomized Controlled Trial
Jouf University
60 participants
Jan 1, 2026
INTERVENTIONAL
Conditions
Summary
This randomized pilot clinical trial aims to evaluate the effectiveness and feasibility of virtual reality (VR)-enhanced parent education in improving neonatal intensive care unit (NICU) caregiving practices among parents of hospitalized neonates. The study will also examine the safety and tolerability of VR use among parents. Researchers will compare VR-enhanced education with standard NICU parent education to determine whether immersive VR training improves parents' knowledge, confidence, and ability to perform caregiving tasks. Participants will be randomly assigned to receive either VR-enhanced education or standard education. Participants receiving VR education will engage in short immersive sessions demonstrating NICU orientation and caregiving procedures. All participants will complete assessments and observations related to caregiving practices and VR tolerability throughout the study period.
Eligibility
Inclusion Criteria4
- Parent or legal guardian of a neonate admitted to the Neonatal Intensive Care Unit (NICU) within 72 hours of admission
- Age 18 years or older
- Able to read and understand the study language (Arabic)
- Willing to provide informed consent and participate in study procedures
Exclusion Criteria3
- Parent with a confirmed diagnosis of epilepsy, vestibular disorder, or any medical condition that contraindicates virtual reality exposure
- Parent of a neonate expected to be discharged or transferred within 48 hours
- Parent unable to complete study procedures or assessments
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants receive virtual reality-enhanced parent education including immersive NICU orientation and caregiving simulation sessions delivered using a VR headset, followed by structured debriefing.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07410858